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Abstract Protein kinase CK2 has been shown to be elevated in 
all so far investigated solid tumors and its catalytic subunit has 
been shown to serve as an oncogene product. CK2 is a hetero- 
tetrameric serine-threonine kinase composed of two catalytic (cu 
and/or cy’) and two regulatory P-subunits. Using the two-hybrid 
system we could show that the (Y- or &-subunits of CK2 can 
interact with the P-subunits of CK2, but not with other (Y- or 
&-subunits. By comparison, the P-subunit of CK2 can interact 
with another P-subunit. Important amino acids for successful 
dimerization of the /?-subunit were localized between amino acid 
residues 156 and 165. Furthermore, we identified residues be- 
tween amino acid 170 and 180 which antagonize the dimerization. 
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1. Introduction 
Protein kinase CK2 is an ubiquitous enzyme found in all so 
far investigated eukaryotic organisms. The high degree of 
amino acid homology from yeast to man suggests an important 
role in the metabolism (for reviews, see [l-5]). Genetic studies 
in Saccharomyces cerevisiae [6,7] show that the catalytic subunit 
is essential for viability. Similar results were obtained using 
Schizosaccharomycespombe [8]. As in S. cerevisiae, overexpres- 
sion of the catalytic subunit did not lead to detectable pheno- 
typic changes. By contrast, CK2B overexpression inhibits cell 
growth and cytokinesis, with formation of multiseptated cells. 
Whereas the function of the a-subunit can be clearly assigned 
to be catalytic and hence can be directly compared with other 
members of the protein kinase family [9], the physiological role 
of the p-subunit only slowly begins to emerge. With the availa- 
bility of recombinant human CK2 [lo] it was possible to assign 
it at least three basic properties: (i) modulating activity [lo, 111, 
(ii) stabilizing the structure [ 121 and (iii) determining substrate 
specificity at [11,13]. For some substates, e.g. calmodulin, the 
p-subunit is a negative regulator. Especially, the latter role will 
be possibly of greater importance in the future than can be 
currently assessed, since so far no regulatory mechanism has 
been found for protein kinase CK2. Whereas the CAMP-de- 
pendent protein kinase, which also consists of two catalytic and 
two regulatory subunits, can be activated by dissociation in the 
presence of CAMP, a similar mechanism has not been found for 
CK2. By contrast, the tetrameric CK2 holoenzyme can only be 
dissociated by boiling in SDS followed by PAGE analysis. 
Hence, it is unlikely that dissociation will ever occur in vivo 
once the tetrameric complex has been formed. Regulation of 
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CK2 activity to wards different substrates probably involves 
modulators influencing the downregulatory capability of 
CK2a-subunits towards certain substrates [14]. In any case, 
knowledge of the structure how the tetrameric complex is 
formed will be a prerequisite in facilitating the understanding 
the regulatory mechanism of CK2a. 
Initial biochemical and biophysical characterization of the 
recombinant human CK2 subunits revealed that the CK2 sub- 
unit behaved as a protein of the predicted molecular mass 
calculated from the cDNA sequence, i.e. 44,000 Da [3]. By 
contrast, the CK2/3-subunit (26,000 Da) showed a Stokes’ ra- 
dius similar to that found for the catalytic subunit in the pres- 
ence of 500 mM KC1 but also under denaturing conditions 
(6 M urea, 2 M NaCl). One explanation was to assume a rod- 
shaped geometry for the CK2p-subunit, alternatively it was 
suggested to exist as a dimer. Sucrose density gradient analysis 
showed that the p-subunit moved to the same position as the 
a-subunit suggesting dimer formation, again a rod-shaped ge- 
ometry was not be ruled out [lS]. Hence, a genetic approach 
using the two-hybrid system was chosen [16]. In addition, sev- 
eral p deletion mutants from the carboxy-terminal end and 
three-point mutations were examined. This allowed mapping of 
the minimum amino acid sequence required for dimerization 
and identification of residues which attenuate dimerizations. 
Results obtained by the two-hybrid system suggest that at least 
one crucial sequence needed for dimerization is localized in the 
carboxy-terminal half between amino acid residues 156165. 
However, the reason for the stable dimer formation is so far 
obscure but it may be required for the subsequent formation 
of the very stable holoenzyme complex. 
While these experiments were just terminated a paper ap- 
peared which reported on the a-, a’- and P-subunit interaction 
of protein kinase CK2 [ 171 albeit with no specific foocus on the 
p-p dimerization. 
2. Materials and methods 
2.1. Materials 
Plasmids encoding the GAL4 DNA-binding domain (pGBT9) or the 
GAL4 transcriptional activation domain (pGAD424). the sequencing 
primers for the two vectors and the yeast strain SFY526 [18] were 
obtained from Clontech. Oligonucleotides were ordered from Eurogen- 
tech (Belgium). The T7 sequencing kit was purchased from Pharmacia. 
2.2. Plasmid constructs 
For cloning of the cDNAs of human CK2cr andb into the p-GAD424 
and pGBT9 vectors, clones pBB3 (CK2a) and pBB4 (CK2/?) [lo] were 
digested with restriction enzymes NdeI and IfindIII, the cDNA frag- 
ments were isolated from agarose gels, filled in and cloned into the SmaI 
site of the vectors. Correct insertion was confirmed by sequencing. The 
encoded fusion proteins contained the complete sequence of the human 
CK2a or B. For cloning of the carboxy-terminal CK2p deletions, the 
plasmid pBB4 was used as a template for polymerase chain reactions. 
The first primer contained the 20 first nucleotides of the coding region 
of the CK2/I cDNA. The second primers were complementary to the 
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20 nucleotides within the CK2B cDNA preceeding the deletions. At its 
5’ end they contained additional nucleotides representing a stop codon 
and a BamHI recognition site. The PCR products were digested with 
XbaI and BamHI and cloned into the XbaUBamHI site of the 
pGAD424/CK2/I construct. The entire sequences of amplified frag- 
ments were confirmed. For cloning of point mutations, already created 
mutants [ 151 served as PCR templates. The primers for the PCR con- 
tained the 20 first nucleotides and the 20 complementary last nucleo- 
tides of the coding region of the human CK2/I cDNA and in addition 
a XbaI and BamHI restrictiction site, respectively. Cloning procedure 
was as described for the carboxy-terminal deletion mutants. The plas- 
mid pGAD-GHICK2a’ encoding a fusion protein between the GAL4 
activation domain and the entire human CK2a’ cDNA was isolated by 
screening a HeLa cDNA library in the vector pGAD-GH with the 
pGBT9ICK2p construct. Details of the screening procedure are de- 
scribed elsewhere (manuscript in prep.), but we essentially followed the 
protocol recommended by Clontech. 
All plasmids were routinely maintained in E. co/i DHSa. 
2.3. Transformation and maintenance of yeast 
Yeast strains were grown and manipulated according to the Clontech 
protocol. For two-hybrid experiments, the yeast strain SFY526 was 
transformed with 100 ng of various pGAD424 and pGBT9 plasmids. 
After selection of transformants single colonies were picked with a 
toothpick, transferred in parallel (i) to a fresh plate and regrown and 
(ii) to a Whatman No. 5 filter paper, which was further incubated on 
a fresh plate for 3 days. The filter was frozen for -5 s in liquid nitrogen, 
then layered over a second filter, prewetted with Z-buffer (16.1 g/l 
Na2HP0, x 7 H,O, 5.5 g/l NaH,PO, x H,O, 0.75 g/l KCl, 0.246 g/l 
MgSO, x 7 H,O) which contained 0.27 ml 2-mercaptoethanol and 1.67 
ml X-gal stock solution (20 mg/ml) per 100 ml. Incubation was at 30°C 
for up to 4 h or until colonies turned blue. 
2.4. Measurement of /I-galactosiduse activity 
Assays for /I-galactosidase activity were performed essentially ac- 
cording to the Clontech protocol. Material from the plate which was 
prepared in parallel to the filter was used for inoculation of 5 ml cultures 
with synthetic medium. The cultures were grown until Aboo = 1 was 
reached. 500 ~1 and 1 ml of each culture was transferred to a microcen- 
trifuge tube and centrifuged for 5 s. The yeast cell pellet was resus- 
pended in 100 ,~l synthetic medium, 700 ~1 Z-buffer with 2-mercap- 
toethanol, 50 ~1 0.1% SDS and 50 ~1 chloroform were added. The 
mixture was vortexed for 30 s. The reaction was started by adding 160 
~1 of 4 mg/ml ONPG in 0.1 M phosphate buffer pH 7.0 and incubated 
for 1 h at 30°C. Reactions were terminated by the addition of 400 ,~l 
1 M Na,CO,. After centrifugation for 10 min the A,,o was measured. 
B-galactosidase activities were calculated in Miller units according to 
the following formula: units = 1000 x &,&culture volume in ml x incu- 
bation time in min x A,,,). 
Table 1 
Quantitative determination of dimerization in the two-hybrid system of 
CK2p fused to GALCbinding domain with C-terminal deletions and 
selected point mutations of CK2p fused to GAL4 activation domain 
CK2 deletions fused CK2”’ fused to 
to GAL4 activation GAL4 binding 
domain domain 
p-galactosidase 
activity 
Miller units 
j (ll215”‘) 
p (l-200) 
B (1-193) 
jl (l-180) 
B (l-170) 
/I (1-165) 
,6 (l-155) 
B (I-149) 
/3”’ (l-215) 
j?“’ (l-215) 
B’“’ (l-215) 
B”’ (1-215) 
j?“’ (1-215) 
/VW’ (l-215) 
/?‘“I (1-215) 
B’“’ (1-215) 
7.5 f 0.89” 
10.1 + 1.89 
7.0 f 1.51 
8.3 ? 2.83 
12.2 * 5.19 
24.2 f 11.17 
1.2 f 1.67 
0.5 ? 0.48 
~Z”” /?’ (1-215) 15.0 f 0.83b 
$*1,, 
/I”” (1-215) 13.0 * 0.70 
j?“” (l-215) 10.1 + 0.44 
“Activity values are the average (+ S.D.) of at least three independent 
sets of experiments. 
bin the case of the single mutations two independent sets of experiments 
were carried out. 
AD+a AD+a’ N+B 
DD+a 
Fig. 1. Filter assay for j?-galactosidase in order to test for qualitative 
interaction between the wildtype subunits of CK2 in the two-hybrid 
system. A streak of individual colonies harboring the CK2 subunit/ 
GAL4 activation domain (AD) and binding domain (BD) constructs 
were allowed to grow on filters and then assayed for /I-galactosidase 
activity. Positive interaction was visualized by the appearance of col- 
ored signals. Constructs used were: AD-a, AD-a’, AD-B, BD-a and 
BD-B. 
3. Results and discussion 
3.1. Dimerization of recombinant human CkT2p 
With the availability of recombinant human CK2 subunits 
[lo] it was possible to carry out extensive biochemical and 
biophysical investigations. Sucrose density gradient analysis of 
the recombinant subunits revealed that the B-subunit (M, 
24.941 kDa) migrated to a similar position as the larger CK2cl- 
subunit (M, 45.141 kDa). These data support the notion that 
the/?-subunit may exist as a dimer which is formed immediately 
after the expression of the recombinant human protein in 
E. coli. To prove this hypothesis, in vivo experiments were de- 
signed using the two-hybrid system [16]. The activation domain 
(AD) of the GAL4 cDNA was fused to the a, a’ or j3 cDNA 
and the binding domain (BD) to the a erg cDNA. Fig. 1 shows 
the results of such an experiment where different possible com- 
binations of CK2 subunits were tested. 
Cotransformation of the yeast strain SFY526 with different 
a, a’ and B hybrids were performed. Interaction between two- 
hybrid proteins were tested by the /I-galactosidase filter assay. 
The obtained results clearly show an interaction between a//3, 
a’//? and J3IjI. There was no interaction between ala and ala’. 
B-Galactosidase expression was not detectable in yeast trans- 
formed with only one CK2 subunit hybrid alone or in combina- 
tion with either the binding or activation domain of GAL4 (not 
shown). 
3.2. Amino acid domain involved in the dimerization 
Next we wanted to answer the question what is the minimum 
required protein size to allow p-/3 interaction. For this purpose, 
we created a set of deletion mutants from the carboxy-terminal 
end (Fig. 2) e.g. l-200, 1-193, l-180, l-170, l-165, 1-155 and 
1-149. These mutants were fused to the activation domain of 
the GAL4 cDNA. Except for mutants l-155 and 1-149, all 
mutants showed interaction with the CK2/?“‘, suggesting that 
the crucial minimum protein size is between l-l 56 (Mr - 17,000) 
and 1-165 (M, -18,000), comprising the sequence 
‘56GAYFGTGFPH’65. Therefore, one can assume a molecule 
size needed for /I dimerization which is smaller than the mini- 
mum size needed for the subsequent interaction with the a- 
subunit which is between l-180 and 1-193 [15]. 
The quantitative determination of B-galactosidase activity 
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involving the various mutants showed that there are significant 
differences among the mutants (Table 1). The wildtype and the 
deletion mutants (l-200; 1-193; l-180; l-170) showed activities 
between 7.1 and 10 U whereas mutants l-155 and 1-149 are 
virtually lacking any significant /3-galactosidase activity. The 
latter result is in agreement with the data we have obtained in 
the filter assay reaction (Fig. 2). 
3.3. Attenuation of dimerization 
Remarkably, however, is the 2 to 3-fold /&galactosidase ac- 
tivity increase observed with mutant 1-165 (24.2 U) in compar- 
ison top (7.5 U) and the deletion mutants l-200; 1-193; and 
l-180 (Table 1). Since an increase in p-galactosidase activity 
directly reflects an increase in dimerization intensity, we assume 
that the removal of amino acid residues 16&215 involves a loss 
of amino acid residues antagonizing dimerization as can be seen 
by a lower B-galactosidase activity (Table 1). Also mutant /?- 
170 (12.2 U) shows still a slightly elevated p-galactosidase activ- 
ity whereas in mutant Bl-180 wildtype activity was measured. 
This suggested to us that somewhere between amino acid 
residues 170 and 180 might be a stretch of amino acids which 
are responsible for attenuation of dimerization. Tackle this 
problem, we created a set of exchange mutants, e.g. A’77,‘78 
(Lys, Arg+Ala), A’75 (Arg-+Ala) and A”’ (His+Ala). We 
focused on the sequence motif ‘75RPKRP’78, where two basic 
amino acids are flanked by prolines and which is 100% con- 
served in the CK2 subunit from man, bovine, Drosophila melan- 
oguster and Xenopus laevis. It is still 93% conserved in nema- 
todes. The mutants A”’ and A”‘,“’ which were already studied 
earlier [15] behaved in most experiments like CK2p. Only in 
western blots with the purified proteins a strong band of the 
BD+p 
AD +B”(l-215) 
m + p (1-200) 
AD + 8 (l-193) 
AD + p (l-180) 
AD + p (l-170) 
AD + p (l-165) 
AD + p (l-153) 
AD + p (1-149) 
Fig. 2. Filter assay for p-galactosidase to test for qualitative interaction 
between the BD;B”’ and various AD constructs containing/P’ but also 
different deletion mutants. For further details, refer to the legend in 
fig. 1. 
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Fig. 3. Hypothetical model of human CK2 tetramer arrangement bas- 
ing on the observation that recombinant human p-subunit behaves like 
a dimer according to its Stokes’ radius and with respect to the results 
in the two-hybrid system. As a first step, the formation of &3 homo- 
dimers is postulated followed by the association of the a- and/or 
a’-subunits. 
molecular mass of a CK2/3 dimer appeared (not shown). This 
led us to the assumption that the amino acids 175, 177 and 178 
might play a role in dimerization. Indeed, Table 1 shows, that 
the double mutant A’77,‘78 where two basic residues were 
changed for alanines, has a 2-fold higher /3-galactosidase activ- 
ity than the wildtype. In case of the A’75 mutant, where only 
one arginine of the ‘75RPKRP’78 sequence motif has been 
changed p-galactosidase activity is al ready lower than in the 
case of the double mutant and it is like the wildtype in the case 
of mutant A171 where a histidine, which is not part of the 
‘7sRPKRP’78 motif, was changed to alanine for control pur- 
poses. 
Many biologically important peptide sequences contain pro- 
line. The conformational restrictions imposed by proline motifs 
in a peptide chain appear to imply important structural or 
biological functions as can be deduced from their often remark- 
ably high degree of conservation found in many peptides and 
proteins [18] as is also the case for CK2/3, too. The conforma- 
tional constraints induced by proline residues in a peptide usu- 
ally restrict proteolysis. Furthermore, the presence of a set of 
basic amino acids surrounded by prolines may be supportive 
in antagonizing otherwise stable structural domains. This could 
explain that deletion of this domain leads to a more intimate 
association of two molecules than it is commonly found be- 
tween two wildtype molecules. From all these information, it 
is obvious that preferably mutations of the basic residues would 
possibly lead to a closer insight in their role in the dimerization 
capability of thep-subunit. Mutations affecting the prolines are 
prohibitive since they may lead to so drastic changes on the 
overall structure. 
Gietz et al. [17] found the strongest interaction for the a-b 
and a’-P interaction but no interaction between a-a. In an 
earlier paper [19], it was shown that the majority of newly 
synthesized p-subunit is rapidly incorporated into complexes 
with the p-subunit. By comparison, the B-subunit is synthesized 
156 
in excess of a and incorporates slowly with a. All these data, 
together with recent findings, where B-,L? interaction was also 
shown by chemical crosslinking (W. Pyerin, pers. commun.) 
and biophysical studies using analytical ultracentrifugation 
(Flossdorf et al. in prep.) support the notion that B dimer 
formation precedes incorporation of a or a’-subunits. Fig. 3 
shows two cartoons of the hypothetical holoenzyme structure. 
They differ from previous ones [20,21] inasmuch that they are 
based on the observation that the p-p dimerization is a prereq- 
uisite for the subsequent association of the a-subunits to com- 
plete the a& structure. 
Clearly, we have to await the complete structural analysis of 
CK2 subunits by X-ray crystallography to obtain the final 
answer for the arrangement of the individual subunits in the 
tetrameric complex. 
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